As an early mediator of inflammation, HMGB1 is implicated in a variety of inflammatory diseases, including sepsis [15], arthritis and pneumonia [16, 17], thereby indicating that HMGB1 maybe be a promising therapeutic target for inflammatory diseases [18]. Here, HMGB1 is linked to susceptibility to pneumonia measurement.